|
Cardiology
Cardiovascular Evaluation for the Strong Heart Study Phase V
Investigator: Devereux, Richard B
Phone Number: 746-2150
Electrocardiographic Analyses in the LIFE Study
Investigator: Devereux, Richard B
Phone Number: 746-2150
LIFE Electrocardiographic Analyses
Investigator: Devereux, Richard B
Phone Number: 746-2150
Registry to Improve the use of Evidence Based Heart Failure Therapies in the Outpatient Setting
Investigator: Farr, Maryjane A
Phone Number: 746-2150
MVP vs. VVI 40 Pacing
Investigator: Iwai, Sei
Phone Number: x6-2158
Multidisciplinary Study of Right Ventricular Dysplasia
Investigator: Lerman, Bruce B
Phone Number: x6-2169
A Long-term, Open-label, Safety Extension of the Combination of Fenofibric Acid and Statin Therapy for Subjects with Mixed
Dyslipidemia
Investigator: Masri, Bassem M
Phone Number: 746-2150
A Multi-Center, Prospective, Randomized, Double-blind, Placebo-controlled Phase III Clinical Outcome Study to Examine ...
Investigator: Masri, Bassem M
Phone Number: 746-2150
A Multicenter, Randomized, Double-Blind, Prospective Study Comparing the Safety and Efficacy of Fenofibric Acid and Atorvastatin
Calcium Combination
Investigator: Masri, Bassem M
Phone Number: 746-2150
A Randomized, Double-blind...Phase III Study of Rosuvastatin (CRESTOR) 20mg in the Primary Prevention of Cardiovascular Events
Among Subjects with....
Investigator: Masri, Bassem M
Phone Number: 746-2150
A Multicenter Registry for the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT REGISTRY)
Investigator: Parikh, Manish A
Phone Number: x-6-2157
A Retrospective Chart review to Fetermine the Risks of Pacemaker and Implantable Cardioverter Defibrillator Generator Changes
Investigator: Stein, Kenneth M
Phone Number: x6-2158
REsynchronization reVErses Remodeling in Systolic left vEentricular dysfunction (REVERSE)
Investigator: Stein, Kenneth M
Phone Number: x6-2158
Registry to Improve the use of Evidence Based Heart Failure Therapies in the Outpatient Setting
Investigator: Stein, Kenneth M
Phone Number: x6-2158
Resynchronization Therapy in Normal QRS (RethinQ)
Investigator: Stein, Kenneth M
Phone Number: x6-2158
Randomized, Multi-Center, Double-blind, Placebo Controlled Trial of the Effects of Erythropoietin on Infarct size and Left
Ventricular Remodeling ...
Investigator: Weinsaft, Jonathan W
Phone Number: 746-2150
A Randomized Controlled Trial of the Medtronic Endeavor Drug (ABT) Eluting Stent System versus the Cypher Sirolimus-Eluting
Coronary Stent System in D
Investigator: Wong, ShingChiu
Phone Number: x6-4789
Assessment of the Medtronic AVE Interceptor Saphenous Vein Graft Filter System (AMEthyst)
Investigator: Wong, ShingChiu
Phone Number: x6-4789
A Double-Blind, Prospective, Randomized, Placebo-Controlled Study to Determine the Tolerability, Efficacy, Safety, and Dose
Range of ...
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
A Mltcntr, Random, Dbl-blind, Dose Ranging Placebo-cntrlld Study Evaluation Defined Doses of Percutaneously Delivered via
Boston Scientific Stiletto E
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
A Muticenter, Single-arm Study of the TAXUS Liberte-SR Stent for the Treatment of Patients with De Novo Coronary Artery Lesions
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
A RCT of the Medtronic Endeavor Drug (ABT-578) Eluting Coronary Stent System versus the TAXUS Paclitaxel-Eluting Coronary...(ENDEAVOR
IV TRIAL)
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
A Randomized Controlled Trial to Evaluate the Safety and Efficacy of the ZoMaxx Drug Eluting Coronary Stent System as compared
to the Taxus Express...
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
Ensure's Vascular Closure Device Speeds Hemostasis Study (ECLIPSE)
Investigator: Wong, Shing Chiu
Phone Number: x6-4789
|
